home / stock / rvxcf / rvxcf short
Short Information | Resverlogix Corp (OTCMKTS:RVXCF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 281,425 |
Total Actual Volume | 493,916 |
Short Trends | |
---|---|
Cover Days | 6 |
Short Days | 11 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 14,071 |
Average Short Percentage | 61.92% |
Is there a RVXCF Short Squeeze or Breakout about to happen?
See the RVXCF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-17-2024 | $0.0409 | $0.04095 | $0.04095 | $0.0404 | 7,006 | 2,500 | 35.68% |
04-09-2024 | $0.04 | $0.0418 | $0.0441 | $0.0399 | 24,825 | 4,275 | 17.22% |
04-04-2024 | $0.035 | $0.0444 | $0.0444 | $0.035 | 9,000 | 1,500 | 16.67% |
04-03-2024 | $0.041 | $0.041 | $0.041 | $0.041 | 700 | 700 | 100% |
03-28-2024 | $0.034 | $0.042 | $0.042 | $0.034 | 3,300 | 1,500 | 45.45% |
03-27-2024 | $0.0411 | $0.0423 | $0.0423 | $0.0411 | 2,150 | 2,000 | 93.02% |
03-21-2024 | $0.0411 | $0.0431 | $0.045 | $0.0411 | 3,050 | 650 | 21.31% |
03-20-2024 | $0.0411 | $0.0459 | $0.046 | $0.0411 | 70,100 | 50,000 | 71.33% |
03-12-2024 | $0.048 | $0.048 | $0.048 | $0.048 | 31,000 | 31,000 | 100% |
03-11-2024 | $0.0447 | $0.0482 | $0.0482 | $0.0447 | 17,050 | 15,000 | 87.98% |
03-06-2024 | $0.042 | $0.042 | $0.042 | $0.042 | 500 | 500 | 100% |
03-04-2024 | $0.04285 | $0.041 | $0.04285 | $0.041 | 53,000 | 2,000 | 3.77% |
03-01-2024 | $0.0462 | $0.0435 | $0.0462 | $0.041 | 98,500 | 49,700 | 50.46% |
02-16-2024 | $0.0487 | $0.0487 | $0.0487 | $0.0487 | 20,000 | 20,000 | 100% |
02-15-2024 | $0.048 | $0.048 | $0.048 | $0.0443 | 37,600 | 8,000 | 21.28% |
02-08-2024 | $0.044 | $0.0526 | $0.0529 | $0.044 | 6,035 | 2,000 | 33.14% |
02-06-2024 | $0.0499 | $0.0499 | $0.0499 | $0.0499 | 2,000 | 2,000 | 100% |
01-23-2024 | $0.0512 | $0.0482 | $0.052 | $0.0482 | 74,000 | 74,000 | 100% |
01-22-2024 | $0.0477 | $0.0477 | $0.0477 | $0.0477 | 100 | 100 | 100% |
01-12-2024 | $0.0519 | $0.04665 | $0.0519 | $0.04665 | 34,000 | 14,000 | 41.18% |
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET Developing safe, epigenetic therapeutics for people suffering from chronic illnesses Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions...
2024-03-27 17:08:02 ET The future of drug development Resverlogix is committed to developing epigenetic therapies for the benefit of patients with chronic disease. Their current clinical program focuses on advancing their lead compound ( apabetalone) and evaluating its th...
Calgary, Alberta--(Newsfile Corp. - February 21, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") today announced that Shawn Lu has stepped down from the Board of Directors, effective today. "We would like to thank Shawn for his contributions and wish him all the best," said ...